ELAN Elanco Animal Health Inc NYSE · United States

Elanco Animal Health (ELAN) news

Elanco Animal Health Inc is a public biotech or pharmaceutical company listed on NYSE under the ticker ELAN, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them.

Latest Elanco Animal Health news

We have not published a story on Elanco Animal Health yet. When there is news, it will appear here.

Elanco Animal Health annual financials

Line	FY2025	FY2024
Revenue	$4.71 billion	$4.44 billion
Research and development	$368.0 million	$344.0 million
Net income (loss)	-$232.0 million	$338.0 million
Cash from operations	$560.0 million	$541.0 million
Cash and equivalents	$545.0 million	$468.0 million

Latest balance sheet, Jun 30, 2026 (10-Q): cash and equivalents $530.0 million.

Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice.

Questions about Elanco Animal Health

What is the ticker symbol of Elanco Animal Health?

Elanco Animal Health Inc trades under the ticker ELAN on NYSE.

Where is Elanco Animal Health listed?

Elanco Animal Health Inc is listed on NYSE.

Which country or territory is Elanco Animal Health listed under?

Our directory records Elanco Animal Health Inc under United States.

Does aibio.space cover Elanco Animal Health?

aibio.space lists Elanco Animal Health Inc among 2,820 public biotech companies and publishes its news here as stories appear.

What was Elanco Animal Health's revenue last year?

$4.71 billion for the fiscal year ended Dec 31, 2025, as reported to the SEC.

Is Elanco Animal Health profitable?

Elanco Animal Health Inc reported a net loss of $232.0 million for the fiscal year ended Dec 31, 2025, and generated $560.0 million of cash from operations, per its annual report to the SEC.

How much does Elanco Animal Health spend on research and development?

$368.0 million in the fiscal year ended Dec 31, 2025, per its annual report.

How much cash does Elanco Animal Health have?

$530.0 million in cash at Jun 30, 2026, per its 10-Q.

Investor discussion: Elanco Animal Health

Members talk about Elanco Animal Health (ELAN). Reader posts, not aibio.space reporting, and not investment advice.

Rules

Securities violations are strictly forbidden. No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information.
Say whether you hold the stock. Every post states long, short or no position.
No paid or sponsored posts. Do not post for anyone who pays or rewards you.
No buy or sell calls and no price targets.
No accusations of crime or fraud against named people unless you link a court filing or a regulator's release that makes them.
No personal details and no spam. No links at all for your first 7 days as a member.

Posts that break the rules may be deleted without notice, and the account restricted or closed. See the terms and the privacy policy.

Stock chart

Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. Open NYSE:ELAN on TradingView.

Listing details

Company: Elanco Animal Health Inc
Ticker: ELAN
Listing: NYSE
Country or territory: United States

Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. Tell us about a change. Work at this company? Claim this page.

Published and maintained by aibio.space. Not investment advice. How we work.

Who manages this page This page is managed by aibio.space. The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. How we work · Terms · Request a correction